Spain studies mixed use of COVID-19 vaccines
The Hindu
Spanish health authorities say they have started giving Pfizer-BioNTech vaccine doses to participants in a government-led study involving young people who received a first dose of the AstraZeneca COVI
Spanish health authorities say they have started giving Pfizer-BioNTech vaccine doses to participants in a government-led study involving young people who received a first dose of the AstraZeneca COVID-19 vaccine. Researchers from Spain's Carlos III Institute want to study the effects of mixing vaccines from different manufacturers as they look for a second dose alternative following very rare brain blood clots linked to the vaccine produced by AstraZeneca. Experts say the risks of the British-Swedish pharmaceutical company's vaccine are less than the clot risk healthy women face while on birth control.More Related News

The draft policy for “Responsible Digital Use Among Students”, released on Monday by the Department of Health and Family Welfare, has recommended that parents set structured routines with clear screen-time rules and prioritise privacy, safety, and open conversation with children on digital well-being.












